Find clinical trials for Lymphoma in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Seattle, WA, USA:
SC262-101 is a Phase 1 study to evaluate SC262 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory bioma...
Phase 1
Seattle, Washington, United States and 2 other locations
This phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diff...
Phase 2
Seattle, Washington, United States
This phase I/II trial studies the safety of acalabrutinib and axicabtagene ciloleucel in treating patients with B-cell lymphoma. Acalabrutin...
Phase 1, Phase 2
Seattle, Washington, United States
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Tacoma, Washington, United States and 71 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Seattle, Washington, United States and 215 other locations
The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during...
Phase 1, Phase 2
Seattle, Washington, United States and 11 other locations
cell therapy (bridging therapy) in patients with large B-cell lymphomas that have come back after a period of improvement (relapsed) or that...
Phase 2
Seattle, Washington, United States
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Seattle, Washington, United States and 67 other locations
patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL) that is newly di...
Phase 2
Seattle, Washington, United States
of this study is to characterize the safety and efficacy profile of ACP-196 (acalabrutinib) in subjects with relapsed or refractory Mantle Cell Lymphoma...
Phase 2
Seattle, Washington, United States and 57 other locations
Clinical trials
Research sites
Resources
Legal